论文部分内容阅读
目的观察盐酸氨溴索治疗新生儿感染性肺炎的疗效和安全性。方法以2014年1月~2015年12月我院就诊并确诊为感染性肺炎的130例新生儿为研究对象，随机分为对照组和治疗组，各65例。对照组采用常规治疗方法，治疗组加用盐酸氨溴索，1w后，比较对照组和治疗组的临床疗效。结果治疗组患者的肺部啰音消失天数、平均住院天数、需人工吸痰次数均少于对照组，两组差异均有统计学意义(<0.05)；治疗组总有效率(95.38%)明显高于对照组(66.15%)，差异有统计学意义(<0.05)；未发现患者出现与盐酸氨溴索药物相关的不良反应。结论盐酸氨溴索在治疗新生儿感染性肺炎方面具有显著的疗效和安全性。“,”Objective To observe the hydrochloric acid ammonium bromide in the efficacy and safety of treatment of neonatal infectious pneumonia. Methods In january 2014~december 2015 to our hospital and diagnosed 130 cases of neonatal infectious pneumonia as the research object. Will be randomly divided into two groups, control group and treatment group of 65 cases in each group. Control group using conventional treatment, the treatment group treated with hydrochloric acid ammonia bromine, after a week after treatment comparing the clinical curative effect of the control group and treatment group. Results The treatment group patients with lung sound disappear days, average hospitalization days, need to artificial sputum suction times are less than the control group, difference between the two groups have statistical significance ( < 0.05);Treatment group total effective rate (95.38%) is significantly higher than the control group (66.15%), the difference between the two groups was statistically significant ( <0.05); Not found that patients with hydrochloric acid ammonia bromine drug related adverse reactions. Conclusion Hydrochloric acid ammonia bromine line in their treatment of neonatal infectious pneumonia has significant curative effect and safety.